v3.26.3
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2026
Summary of Significant Accounting Policies [Abstract]  
Schedule of Property and Equipment Estimated Useful Lives

The Company depreciates its property and equipment for financial reporting purposes using the straight-line method over the estimated useful lives of the assets. The estimated useful lives are as follows:

 

Building   40 years
Building improvements   15 years
Land improvements   15 years
Machinery & equipment   5 years
Schedule of Property and Equipment

Property and equipment consisted of the following as of September 30, 2026 and December 31, 2025:

 

    September 30,
2026		     December 31,
2025		  
Land improvements   $ 60,137     $ 60,137  
Buildings     1,302,401       1,302,401  
Building improvements     2,275,583       2,275,583  
Machinery and equipment     2,210,266       2,204,815  
Total property and equipment     5,848,387       5,842,936  
Less: accumulated depreciation     (3,963,622 )     (3,820,893 )
Property and equipment, net   $ 1,884,765     $ 2,022,043  
Schedule of Intangible Assets Intangible assets consisted of the following as of September 30, 2026 and December 31, 2025:

 

    September 30,
2026		     December 31,
2025		  
Issued patents            
Gross carrying amount   $ 1,644,787     $ 1,585,894  
Less: accumulated amortization     (808,939 )     (749,467 )
Issued patents, net     835,848       836,427  
Patents pending (not amortized)     1,179,532       1,155,196  
Total intangible assets, net   $ 2,015,380     $ 1,991,623  
Schedule of Potentially Dilutive Common Stock Equivalents

The following table presents potentially dilutive common stock equivalents that have been included in the calculation of dilutive income per share for the three months ended September 30, 2026, as their inclusion would be dilutive.

 

    September 30,
2026		  
Warrants - Series A     53,240  
Stock-based compensation - equity awards     43,333  
Total common stock equivalents included in dilutive income per share     96,573  

The following table presents potentially dilutive common stock equivalents that have been excluded from the calculation of dilutive loss per share for the nine months ended September 30, 2026, as their inclusion would be anti-dilutive: 

 

    September 30,
2026		  
Holdback Shares     4,000  
Warrants - Public     123,500  
Warrants - Private     108,100  
Warrants - Series A     93,651  
Placement Agent Warrants     116,650  
Stock-based compensation - equity awards     6,000  
Stock-based compensation - warrants     12,000  
Total common stock equivalents excluded from dilutive loss per share     463,901  

The following table presents potentially dilutive common stock equivalents that have been excluded in the calculation of dilutive income per share for the three months ended September 30, 2025, as their inclusion would be anti-dilutive.

 

    September 30,
2025		  
Holdback Shares     4,000  
Warrants - Public     123,500  
Warrants - Private     108,100  
Warrants - Series A     652,857  
Warrants - Series C     2,461,538  
Warrants - Series D     244,349  
Stock-based compensation - equity awards     38,000  
Stock-based compensation - warrants     12,000  
Arbor Lake Strategic Cooperation Consulting Agreement     40,000  
HBC Earnout Shares     450,000  
Total common stock equivalents excluded from dilutive loss per share     4,134,344  

The following table presents potentially dilutive common stock equivalents that have been included in the calculation of dilutive income per share for the nine months ended September 30, 2025, as their inclusion would be dilutive.

 

    September 30,
2025		  
Warrants - Series A     414,909  
Warrants - Series C     1,519,476  
Stock-based compensation - equity awards     37,417  
Total common stock equivalents included in dilutive income per share     1,971,802